Team uses AlphaFold AI to redesign gene-editing proteins to make them safer
Stay on target Team uses AlphaFold AI to redesign gene-editing proteins to make them safer Google’s AlphaFold can help ID what parts of a gene editing protein enable mistakes. One challenge these developments have faced is safety. While we can make them pretty specific to the gene we want edited, the human genome is very large, and even rare DNA sequences can appear a couple of times by chance.
- ▪Stay on target Team uses AlphaFold AI to redesign gene-editing proteins to make them safer Google’s AlphaFold can help ID what parts of a gene editing protein enable mistakes.
- ▪One challenge these developments have faced is safety.
- ▪While we can make them pretty specific to the gene we want edited, the human genome is very large, and even rare DNA sequences can appear a couple of times by chance.
Hacker News (AI / LLM) files mainly under ai. We currently carry 3,327 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Ars Technica |
| Canonical URL | https://arstechnica.com/science/2026/07/team-uses-alphafold-ai-to-redesign-gene-editing-proteins-to-make-them-safer/ |
| Publication time | Fri, 24 Jul 2026 18:33:21 +0000 |
| Retrieval time | 2026-07-24T18:59:21.040Z |
| Last seen | 2026-07-24T18:59:21.040Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 9inWdaCgd2d0 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Stay on target Team uses AlphaFold AI to redesign gene-editing proteins to make them safer Google’s AlphaFold can help ID what parts of a gene editing protein enable mistakes. John Timmer – Jul 24, 2026 1:31 pm | 5 Credit: Anton Vierietin Credit: Anton Vierietin Text settings Story text Size Small Standard Large Width * Standard Wide Links Standard Orange * Subscribers only Learn more Minimize to nav A couple of decades after the discovery of systems that could selectively target DNA, we’re starting to see the first therapies based on gene editing. One challenge these developments have faced is safety. While we can make them pretty specific to the gene we want edited, the human genome is very large, and even rare DNA sequences can appear a couple of times by chance.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Ars Technica.
Discussion
0 commentsMore from Ars Technica
